Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India

被引：0

作者：

Singh, Rudra Pratap ^{[2
]}

Picado, Albert ^{[1
,3
]}

Alam, Shahnawaz ^{[2
]}

Hasker, Epco ^{[3
]}

Singh, Shri Prakash ^{[2
]}

Ostyn, Bart ^{[3
]}

Chappuis, Francois ^{[4
]}

Sundar, Shyam ^{[2
]}

Boelaert, Marleen ^{[3
]}

机构：

[1] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, E-08036 Barcelona, Spain

[2] Banaras Hindu Univ, Varanasi 221005, Uttar Pradesh, India

[3] Inst Trop Med, B-2000 Antwerp, Belgium

[4] Univ Hosp Geneva, Geneva, Switzerland

来源：

TROPICAL MEDICINE & INTERNATIONAL HEALTH | 2012年 / 17卷 / 11期

关键词：

Post-kala-azar dermal leishmaniasis; PKDL; Leishmania donovani; visceral leishmaniasis; kala azar; Bihar; leishmaniose cutanee post kala-azar; PKLD; leishmaniose viscerale; kala-azar; leishmaniasis cutanea post-kala-azar; LCPK; leishmaniasis visceral; AMPHOTERICIN-B; PKDL; MILTEFOSINE; NEPAL;

D O I：

10.1111/j.1365-3156.2012.03067.x

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

We assessed the prevalence of post-kala-azar dermal leishmaniasis (PKDL), a late cutaneous manifestation of visceral leishmaniasis (VL), in 16 VL-endemic communities in Bihar, India. The prevalence of confirmed PKDL cases was 4.4 per 10 000 individuals and 7.8 if probable cases were also considered. The clinical history and treatment of the post-kala-azar dermal leishmaniasis cases are discussed.

引用

页码：1345 / 1348

页数：4

共 50 条

[21] Monitoring of Parasite Kinetics in Indian Post-Kala-azar Dermal Leishmaniasis
Moulik, Srija
Chaudhuri, Surya Jyati
Sardar, Bikash
Ghosh, Manab
Saha, Bibhuti
Das, Nilay Kanti
Chatterjee, Mitali
CLINICAL INFECTIOUS DISEASES, 2018, 66 (03) : 404 - 410
[22] Histopathological features in leprosy, post-kala-azar dermal leishmaniasis, and cutaneous leishmaniasis
Singh, Avninder
Ramesh, V.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2013, 79 (03) : 360 - 366
[23] Adverse ocular events on miltefosine treatment for post-kala-azar dermal leishmaniasis in India
Saurabh, Surnan
Mahabir, Manish
TROPICAL DOCTOR, 2020, 50 (01) : 37 - 42
[24] Utility of Blood as the Clinical Specimen for the Molecular Diagnosis of Post-Kala-Azar Dermal Leishmaniasis
Dixit, Keerti Kaumudee
Ramesh, V
Upadhyay, Shreya
Singh, Abhishek Kumar
Singh, Om Prakash
Sundar, Shyam
Singh, Ruchi
Salotra, Poonam
JOURNAL OF CLINICAL MICROBIOLOGY, 2021, 59 (09)
[25] Amphotericin B Deoxycholate Treatment of Post-Kala-Azar Dermal Leishmaniasis in India
Sundar, Shyam
Chakravarty, Jaya
Singh, Jitendra
Verma, Deepak
Agrawal, Neha
Dinkar, Anju
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2024, 111 (01) : 59 - 63
[26] Pathology and Mechanism of Disease in Kala-Azar and Post-kala-azar Dermal Leishmaniasis
Hossain, Moazzem
Jamil, Kazi M.
KALA AZAR IN SOUTH ASIA: CURRENT STATUS AND CHALLENGES AHEAD, 2011, : 11 - +
[27] Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial
Sundar, Shyam
Sinha, Prabat
Jha, T. K.
Chakravarty, Jaya
Rai, Madhukar
Kumar, Nawin
Pandey, Krishna
Narain, M. K.
Verma, N.
Das, V. N. R.
Das, P.
Berman, Jonathan
Arana, Byron
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2013, 18 (01) : 96 - 100
[28] Post-kala-azar dermal leishmaniasis in pregnancy: hitherto unaccounted
Verma, Prashant
Grover, Chander
Sharma, Sonal
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (12) : 1501 - 1504
[29] Genetic heterogeneity among visceral and post-Kala-Azar dermal leishmaniasis strains from eastern India
Dey, Ayan
Singh, Sarman
INFECTION GENETICS AND EVOLUTION, 2007, 7 (02) : 219 - 222
[30] AmBisome for Kala-azar and Post-kala-azar Dermal Leishmaniasis: An Essential Option but Not a Universal Solution Reply
den Boer, Margriet
Burza, Sakib
CLINICAL INFECTIOUS DISEASES, 2019, 69 (01) : 190 - 190

← 1 2 3 4 5 →